Free Trial
LON:RLM

Realm Therapeutics (RLM) Share Price, News & Analysis

About Realm Therapeutics Stock (LON:RLM)

Key Stats

Today's Range
N/A
50-Day Range
11.50
11.50
52-Week Range
N/A
Volume
169,853 shs
Average Volume
800,861 shs
Market Capitalization
£13.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Realm Therapeutics Plc, a biopharmaceutical company, focuses on developing therapies for the treatment of immune-mediated diseases in adults and children. Its product pipeline includes PRO22, a topical gel, which is conducting initial Phase II clinical studies for the treatment of atopic dermatitis. The company was formerly known as PuriCore plc and changed its name to Realm Therapeutics Plc in December 2016. Realm Therapeutics Plc was founded in 2016 and is headquartered in Malvern, Pennsylvania.

Receive RLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Realm Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RLM Stock News Headlines

EPI:CA ESSA Pharma Inc.
Let’s be blunt
Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!
Defence of the Realm Act (DORA)
Realm Therapeutics PLC ADR (RLM_old)
See More Headlines

RLM Stock Analysis - Frequently Asked Questions

Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX) and Ampio Pharmaceuticals (AMPE).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Steel Works
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£501,919.00
Book Value
GBX 20.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£13.41 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (LON:RLM) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners